Skip to main content

Table 1 Characteristics of the 95 patients taking part in the study

From: Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care

 

Asthma n(%)

COPD/Both n(%)

All n(%)

All

46 (48.4)

49 (51.6)

95 (100)

Age 65 years or more

17 (37.0)

28 (57.1)

45 (47.4)

Gender

   

Male

17 (37.0)

18 (36.7)

35 (36.8)

Female

29 (63.0)

31 (63.3)

60 (63.2)

Smoking status

   

Never smoker

18 (39.1)

8 (16.3)

26 (27.4)

Current smoker

12 (26.1)

18 (36.7)

30 (31.6)

Ex-smoker

16 (34.8)

23 (46.9)

39 (41.1)

Spirometry at baseline

   

FEV1/FVC < 0.7

7 (15.2)

32 (65.3)

39 (41.1)

Respiratory symptoms

   

Dyspnea, bothersome or very bothersome

42 (91.3)

47 (95.9)

89 (93.7)

very bothersome

12 (26.1)

19 (38.8)

31 (32.6)

Phlegm, bothersome or very bothersome

35 (76.1)

36 (73.5)

71 (74.7)

very bothersome

9 (19.6)

9 (18.4)

18 (18.9)

Purulence

23 (50.0)

21 (42.9)

44 (46.3)

Coughing, bothersome or very bothersome

42 (91.3)

43 (87.8)

85 (89.5)

very bothersome

16 (34.8)

15 (30.6)

31 (32.6)

Chest findings

   

Prolonged expiration

16 (34.8)

26 (53.1)

42 (44.2)

Wheezes/rhonchi

16 (34.8)

31 (63.3)

47 (49.5)

Diminished breath sounds

4 (8.7)

15 (30.6)

19 (20.0)

Crackles

10 (21.7)

18 (36.7)

28 (29.5)

Any abnormal chest finding

24 (52.2)

39 (79.6)

63 (66.3)

Admitted to hospital due to exacerbation the year before baseline

3 (6.6)

3 (6.1)

6 (6.4)

Exacerbation treated with antibiotics the year before baseline

13 (28.3)

24 (49.0)

37 (38.9)

Exacerbation treated with systemic corticosteroids the year before baseline

7 (15.2)

24 (49.0)

31 (32.6)